| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/16/2003 | EP1326882A2 Enterokinase cleavage sequences and their use |
| 07/16/2003 | EP1326880A1 Method for the selective modification of peptides and proteins |
| 07/16/2003 | EP1326523A2 Imaging of enzymatic activity |
| 07/16/2003 | EP0975354A4 Ligand/lytic peptide compositions and methods of use |
| 07/16/2003 | CN1114876C Method for auxiliary detecting latent analogies of erythropoietin by computer and screening compound by the method |
| 07/15/2003 | US6593459 Compound for use in the treatment of cancer |
| 07/15/2003 | US6593300 Inhibitors of the interleukin-1 beta converting enzyme |
| 07/15/2003 | US6593295 Long lasting insulinotropic peptides |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/15/2003 | US6592871 Partial sequences of the C-100-3 and env/core with C-regions |
| 07/15/2003 | US6592865 Increasing vasoconstriction using angiotensin II potentiated with angiotesin 1-9 |
| 07/15/2003 | US6592847 Intramolecularly-quenched near infrared flourescent probes |
| 07/10/2003 | WO2003056339A1 Screening methods and the use of agents identified using the same |
| 07/10/2003 | WO2003056299A2 Labeling reagent and methods of use |
| 07/10/2003 | WO2003056297A2 Self-assembling polymers, and materials fabricated therefrom |
| 07/10/2003 | WO2003055903A1 Transcription regulatory gene and peptide |
| 07/10/2003 | WO2003055902A1 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 07/10/2003 | WO2003055900A1 Peptide purification |
| 07/10/2003 | WO2001086296A3 Highly multiplexed reporter carrier systems |
| 07/10/2003 | US20030131383 Peptides with enhanced stability to protease degradation |
| 07/10/2003 | US20030130200 Tripeptide or tetrapeptide |
| 07/10/2003 | US20030130173 Bactericides for drug resistant bacteria |
| 07/10/2003 | US20030129675 Assaying the ability of a compound to block the binding of an alpha 4 integrin to a binding partner thereof |
| 07/10/2003 | CA2462768A1 Self-assembling polymers, and materials fabricated therefrom |
| 07/09/2003 | EP1325931A1 Inhibitors of human neutrophil elastase |
| 07/09/2003 | EP1325739A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 07/09/2003 | EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1000177A4 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 07/09/2003 | EP0964690B1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | CN1428144A Method for preparing mass micro-capsule |
| 07/09/2003 | CN1114106C Peptide marked with metal chelate and preparing method thereof |
| 07/08/2003 | US6590073 Providing solution comprising an echinocandin compound, an aldehyde impurity and solvent; concentrating by nanofiltration to form concentrate; adding derivatizing agent to react with aldehyde; adjusting pH, adding acid or metal salt; cooling |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589937 Peptides and nootropic agent |
| 07/08/2003 | CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") |
| 07/03/2003 | WO2003054146A2 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 07/03/2003 | WO2003054001A2 Method for preparing echinocandin derivatives and their compositions |
| 07/03/2003 | WO2003054000A1 Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 07/03/2003 | WO2003053473A2 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | WO2003053457A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 07/03/2003 | WO2002099379A3 Breast homing peptides and methods of identifying same using aminopeptidase p |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | WO2002014867A3 Ultra-sensitive detection systems |
| 07/03/2003 | US20030125561 Triazole or imidazole oxide compound with a positively charged electron withdrawing group (a quaternary nitrogen containing amidine or imine group); useful in effecting the acylation step in amide formation (peptide synthesis) |
| 07/03/2003 | US20030125517 Lipopeptides; virosomal delivery systems for transporting drugs, nucleic acids and proteins |
| 07/03/2003 | US20030125516 Preparing T-1249 and T-1249-like amino acid sequences; viricides |
| 07/03/2003 | US20030125261 Administering to the mammal a therapeutically acceptable amount of a penta or hexapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125260 Administering to the mammal a therapeutically acceptable amount of a tetra or pentapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin |
| 07/03/2003 | US20030125243 Synthesis of cyclic peptides |
| 07/03/2003 | US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 07/03/2003 | US20030125240 Cyclic peptide antifungal agents |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124120 Quinolone vitronectin receptor antagonist pharmaceuticals |
| 07/03/2003 | US20030124115 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 07/03/2003 | CA2471110A1 Peptides for treatment of the human papillomavirus(hpv)-associated cancer and other epithelial tumors |
| 07/03/2003 | CA2470976A1 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | CA2469918A1 Method for preparing echinocandin derivatives and their compositions |
| 07/03/2003 | CA2451993A1 Polypeptide, its conjugate with doxorubicin and conjugate-based pharmaceutical composition |
| 07/02/2003 | EP1323731A1 Novel peptides |
| 07/02/2003 | EP1323730A1 Novel polypeptides and anti-hiv drugs containing the same |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322321A2 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 07/02/2003 | EP1322288A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 07/02/2003 | EP1226158B1 Process for preparing peptide intermediates |
| 07/02/2003 | CN1427725A Casein derived peptides and uses thereof in therapy |
| 07/02/2003 | CN1113067C New active peptide and production thereof |
| 07/01/2003 | US6586403 Treating allergic reactions and inflammatory responses with tri-and dipeptides |
| 07/01/2003 | US6586402 Leucine replaced by neopentylglycine or adamantylalanine |
| 07/01/2003 | US6586396 Subcutaneous administration of natriuretic peptide |
| 07/01/2003 | US6586393 Cyclic peptide antibiotics from Actinomadura sp. of given formula; selective inhibitory activity against E. coli RNA polymerase; use treating infections |
| 07/01/2003 | CA2069654C Peptide process |
| 06/26/2003 | WO2003052122A2 Gp41 inhibitor |
| 06/26/2003 | WO2003052064A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 06/26/2003 | WO2003051910A2 Inhibitors of hepatitis c virus protease |
| 06/26/2003 | WO2003051909A2 Process for the manufacture of pharmaceutically acceptable salts of a compound |
| 06/26/2003 | WO2003051835A2 Methods and compositions for the inhibition of viral release |
| 06/26/2003 | WO2003051377A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 06/26/2003 | WO2003051272A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 06/26/2003 | WO2002016412A3 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 06/26/2003 | US20030120032 N-methyl-homocysteines and their use as well as process for their production |
| 06/26/2003 | US20030119856 Thiazole compounds useful as inhibitors of protein kinase |
| 06/26/2003 | US20030119752 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
| 06/26/2003 | US20030119750 Use of dipeptidyl peptidase IV inhibitors |
| 06/26/2003 | US20030119746 Treatment of both primary and metastatic solid tumors |
| 06/26/2003 | US20030119745 Treatment of both primary and metastatic solid tumors |
| 06/26/2003 | US20030119727 FVIIa antagonists |
| 06/26/2003 | US20030119725 Internalization by a broad host cell spectrum; delivery of diagnostics and therapeutics |
| 06/26/2003 | US20030119189 Method for delivery of molecules to intracellular targets |